Australia, April 1 -- Korro Bio Inc., owns the trademark (2475265) for 'CHORD' till Aug. 19, 2034.
Status: registered:
Registered/protected
Classes: 5 [Oligonucleotide preparations for the treatment of genetic diseases], 40 [Custom manufacture of biomedical compounds comprised of nucleotide polymers and biomedical compounds comprised of ribonucleic acid polymers all for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders for others; Custom manufacture and processing of human cells for medical purposes for others; Treatment of therapeutic cells for others, namely, pharmacological treatment and processing of therapeutic cells to modify their function for therapeutic purposes], 42 [Pharmaceutical research and development; Pharmaceutical research and development in the fields of gene therapies, gene editing, drug discovery and development; Pharmaceutical research and development incorporating artificial intelligence; Pharmaceutical research and development incorporating genetic learning; Scientific and industrial research; Scientific and industrial research incorporating artificial intelligence; Scientific and industrial research in the field of gene therapies, gene editing, drug discovery and development incorporating genetic learning], 5 [Oligonucleotide preparations for the treatment of genetic diseases], 40 [Custom manufacture of biomedical compounds comprised of nucleotide polymers and biomedical compounds comprised of ribonucleic acid polymers all for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders for others;Custom manufacture and processing of human cells for medical purposes for others;Treatment of therapeutic cells for others, namely, pharmacological treatment and processing of therapeutic cells to modify their function for therapeutic purposes] and 42 [Pharmaceutical research and development;Pharmaceutical research and development in the fields of gene therapies, gene editing, drug discovery and development;Pharmaceutical research and development incorporating artificial intelligence;Pharmaceutical research and development incorporating genetic learning;Scientific and industrial research;Scientific and industrial research incorporating artificial intelligence;Scientific and industrial research in the field of gene therapies, gene editing, drug discovery and development incorporating genetic learning]
Type of Mark: Word
Date of Acceptance: Jan. 22
Registration Advertised: March 31
For further details contact PHILLIPS ORMONDE FITZPATRICK.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2475265.
Disclaimer: Curated by HT Syndication.
